As of 2025-07-11, the Intrinsic Value of Pangenomic Health Inc (NARA.CN) is -3.17 CAD. This NARA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.10 CAD, the upside of Pangenomic Health Inc is -387.76%.
Based on its market price of 1.10 CAD and our intrinsic valuation, Pangenomic Health Inc (NARA.CN) is overvalued by 387.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.17 - -3.17 | -3.17 | -387.76% |
| DDM - Stable | (3.51) - (6.82) | (5.16) | -569.5% |
| DDM - Multi | (2.49) - (3.78) | (3.00) | -373.2% |
| Market Cap (mil) | 4.75 |
| Beta | 2.73 |
| Outstanding shares (mil) | 4.31 |
| Enterprise Value (mil) | 4.72 |
| Market risk premium | 5.10% |
| Cost of Equity | 17.48% |
| Cost of Debt | 5.00% |
| WACC | 14.89% |